dupilumab
sanofi,regeneron
['dupilumab', 'derm']
patients with pn who had severe itch and high lesion counts and whose condition was inadequately controlled with prior therapies, experienced significant improvements with dupilumab, indicate results from liberty-pn prime trial. #eadvcongress #dermtwitter 
Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.